Issue: March 2016
February 19, 2016
1 min read
Save

Pharmacological agents offer most effective myopia control

Issue: March 2016
You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

High-dose, moderate-dose and low-dose atropine showed the best control of myopia progression, according to a study recently published in Ophthalmology.

In their meta-analysis of 30 randomized control trials, Huang and colleagues also concluded that pirenzepine, orthokeratology, peripheral defocus modifying contact lenses, cyclopentolate and prismatic bifocal spectacle lenses showed moderate effects in myopia progression.

Progressive-addition spectacle lenses, bifocal spectacle lenses, peripheral defocus modifying spectacle lenses and more outdoor activities resulted in weak effects, according to the researchers. Gas-permeable contact lenses, soft contact lenses, undercorrected single vision spectacle lenses and timolol were ineffective.

In addition, Asian children benefited more from treatment than Caucasian children, and most interventions lose their early effect in the second year, based on the study results.

The researchers concluded that low-dose atropine, pirenzepine and soft contact lenses with myopia control features are the best options for managing myopia progression. – by Abigail Sutton

Disclosure: The researchers reported no relevant financial disclosures.